155 results on '"Usuda, Haruki"'
Search Results
2. Fusobacterium in oral bacterial flora relates with asymptomatic brain lesions
3. A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease
4. Endothelial connexin-integrin crosstalk in vascular inflammation
5. Dietary Fiber Deficiency Accelerates Colitis in Mice in the Short Term Independent of Short-Chain Fatty Acids.
6. Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial
7. Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study
8. A prospective interventional trial on the effect of periodontal treatment on Fusobacterium nucleatum abundance in patients with colorectal tumours
9. Juvenile social defeat stress exposure favors in later onset of irritable bowel syndrome-like symptoms in male mice
10. Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease
11. Reduced substrate stiffness promotes M2-like macrophage activation and enhances peroxisome proliferator-activated receptor γ expression
12. Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design
13. Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial
14. 血管内皮細胞におけるホルネリンの発現と血管新生に及ぼす役割
15. Patients with cardiovascular diseases exhibit distinct characteristics in their oral microbiome and are more susceptible to infections by pathogenic bacteria.
16. Periodontal Treatment and Usual Care for Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized Controlled Trial
17. Transient Receptor Potential Vanilloid 1 — a Polymodal Nociceptive Receptor — Plays a Crucial Role in Formaldehyde-Induced Skin Inflammation in Mice
18. Differential Expression of Pro-inflammatory and Pro-coagulant Genes in Endothelial Cells Induced by Porphyromonas gingivalis Lipopolysaccharide, Escherichia coli Lipopolysaccharide, and Zymosan
19. Oral microbiome in eosinophilic esophagitis
20. Increased permeability of intestinal mucosa and multi-organ association: Leaky Gut Syndrome as a target for drug discovery.
21. Up-regulated miR-199a-3p and miR-126-3p promote adipocyte differentiation by targeting HIF-1α
22. Extracellular substrate stiffness-mediated regulation of endothelial cell function
23. Endotoxins and Non-Alcoholic Fatty Liver Disease
24. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target
25. Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier
26. Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening
27. Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease
28. Lacking dietary fiber enhances sensitivity to inflammatory stimuli, that results in intestinal hyper-permeability.
29. Recombinant soluble thrombomodulin reduces lipopolysaccharide-induced endothelial cellular stiffening
30. Efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study
31. Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease
32. Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening
33. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota
34. The efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation
35. Analysis of oral pathogenic bacteria in the patients of eosinophilic esophagitis
36. Impact of extracellular substrate stiffness on macrophage activation
37. Efficacy of Lubiprostone in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase 2A Trial
38. Simulator-based pharmacological practice using iPad-Cloud system for medical education
39. Expression analysis of mast cell-related genes in fetal and neonatal periods of spontaneously hypertensive rats (SHR)
40. The Functional Implications of Endothelial Gap Junctions and Cellular Mechanics in Vascular Angiogenesis
41. Histological Detection of mmcp-4 Expressing Cells by In Situ RT-PCR Method
42. Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression
43. GS-01-Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease: The LUBIPRONE, doubleblind, randomized, placebo-controlled, phase II study
44. FRI-312-Increased levels of bile acid in feces plays an important role in pathophysiology of non-alcoholic steatohepatitis
45. The Functional Implications of Endothelial Gap Junctions and Cellular Mechanics in Vascular Angiogenesis
46. Blockade of gap junction increases endothelial cellular stiffness
47. Simulator-based pharmacological practice using iPad-Cloud system for medical education
48. Blockade of gap junction increases endothelial cellular stiffness
49. The Functional Implication for Endothelial Gap Junction and Cellular Mechanics in Vascular Angiogenesis
50. Endothelial cell reduces gap junction intercellular communication and increases cellular stiffness upon inflammation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.